Miller CE, Kim JH, Kroll R, Simon JA, et al. Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial. Am J Obstet Gynecol 2024 Jun 30:S0002-9378(24)00731.
PMID: 38955323